PortfoliosLab logoPortfoliosLab logo
NNOX vs. PGNY
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

NNOX vs. PGNY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nano-X Imaging Ltd. (NNOX) and Progyny, Inc. (PGNY). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

NNOX vs. PGNY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
NNOX
Nano-X Imaging Ltd.
-13.93%-61.11%13.03%-13.69%-49.24%-68.16%110.41%
PGNY
Progyny, Inc.
-34.35%48.87%-53.60%19.36%-38.13%18.78%44.28%

Fundamentals

Market Cap

NNOX:

$155.02M

PGNY:

$1.51B

EPS

NNOX:

-$0.87

PGNY:

$0.65

PS Ratio

NNOX:

12.56

PGNY:

1.17

PB Ratio

NNOX:

0.99

PGNY:

2.92

Total Revenue (TTM)

NNOX:

$12.30M

PGNY:

$1.29B

Gross Profit (TTM)

NNOX:

-$12.16M

PGNY:

$304.48M

EBITDA (TTM)

NNOX:

-$44.73M

PGNY:

$94.01M

Returns By Period

In the year-to-date period, NNOX achieves a -13.93% return, which is significantly higher than PGNY's -34.35% return.


NNOX

1D
6.17%
1M
-2.03%
YTD
-13.93%
6M
-34.69%
1Y
-50.10%
3Y*
-25.25%
5Y*
-43.36%
10Y*

PGNY

1D
-0.71%
1M
-4.20%
YTD
-34.35%
6M
-20.55%
1Y
-26.98%
3Y*
-19.33%
5Y*
-18.06%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NNOX vs. PGNY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NNOX
NNOX Risk / Return Rank: 1010
Overall Rank
NNOX Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
NNOX Sortino Ratio Rank: 99
Sortino Ratio Rank
NNOX Omega Ratio Rank: 1313
Omega Ratio Rank
NNOX Calmar Ratio Rank: 1111
Calmar Ratio Rank
NNOX Martin Ratio Rank: 1010
Martin Ratio Rank

PGNY
PGNY Risk / Return Rank: 1616
Overall Rank
PGNY Sharpe Ratio Rank: 1818
Sharpe Ratio Rank
PGNY Sortino Ratio Rank: 1818
Sortino Ratio Rank
PGNY Omega Ratio Rank: 1818
Omega Ratio Rank
PGNY Calmar Ratio Rank: 2020
Calmar Ratio Rank
PGNY Martin Ratio Rank: 88
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NNOX vs. PGNY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nano-X Imaging Ltd. (NNOX) and Progyny, Inc. (PGNY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NNOXPGNYDifference

Sharpe ratio

Return per unit of total volatility

-0.74

-0.52

-0.22

Sortino ratio

Return per unit of downside risk

-1.12

-0.50

-0.62

Omega ratio

Gain probability vs. loss probability

0.89

0.93

-0.05

Calmar ratio

Return relative to maximum drawdown

-0.83

-0.60

-0.22

Martin ratio

Return relative to average drawdown

-1.46

-1.54

+0.08

NNOX vs. PGNY - Sharpe Ratio Comparison

The current NNOX Sharpe Ratio is -0.74, which is lower than the PGNY Sharpe Ratio of -0.52. The chart below compares the historical Sharpe Ratios of NNOX and PGNY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


NNOXPGNYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.74

-0.52

-0.22

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.48

-0.33

-0.16

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.32

0.01

-0.34

Correlation

The correlation between NNOX and PGNY is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

NNOX vs. PGNY - Dividend Comparison

Neither NNOX nor PGNY has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

NNOX vs. PGNY - Drawdown Comparison

The maximum NNOX drawdown since its inception was -97.61%, which is greater than PGNY's maximum drawdown of -79.49%. Use the drawdown chart below to compare losses from any high point for NNOX and PGNY.


Loading graphics...

Drawdown Indicators


NNOXPGNYDifference

Max Drawdown

Largest peak-to-trough decline

-97.61%

-79.49%

-18.12%

Max Drawdown (1Y)

Largest decline over 1 year

-62.52%

-40.68%

-21.84%

Max Drawdown (5Y)

Largest decline over 5 years

-95.59%

-79.49%

-16.10%

Current Drawdown

Current decline from peak

-97.30%

-74.71%

-22.59%

Average Drawdown

Average peak-to-trough decline

-82.16%

-41.67%

-40.49%

Ulcer Index

Depth and duration of drawdowns from previous peaks

35.44%

15.91%

+19.53%

Volatility

NNOX vs. PGNY - Volatility Comparison

Nano-X Imaging Ltd. (NNOX) has a higher volatility of 13.77% compared to Progyny, Inc. (PGNY) at 7.85%. This indicates that NNOX's price experiences larger fluctuations and is considered to be riskier than PGNY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


NNOXPGNYDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.77%

7.85%

+5.92%

Volatility (6M)

Calculated over the trailing 6-month period

53.48%

43.44%

+10.04%

Volatility (1Y)

Calculated over the trailing 1-year period

67.96%

52.03%

+15.93%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

89.71%

55.34%

+34.37%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

100.88%

61.74%

+39.14%

Financials

NNOX vs. PGNY - Financials Comparison

This section allows you to compare key financial metrics between Nano-X Imaging Ltd. and Progyny, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M300.00M350.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
3.45M
318.40M
(NNOX) Total Revenue
(PGNY) Total Revenue
Values in USD except per share items